Cargando…

Efficacy and safety of sugammadex in patients undergoing renal transplantation

BACKGROUND: Sugammadex reverses rocuronium by encapsulating it, creating a stable complex that is mainly excreted by the kidneys. Nonetheless, in view of exposure to sugammadex during renal transplantation, current safety data are insufficient. We retrospectively investigated the safety and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ono, Yasumasa, Fujita, Yoshihito, Kajiura, Takahiro, Okawa, Hazuki, Nakashima, Juntaro, Isobe, Hideo, Fujiwara, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966977/ https://www.ncbi.nlm.nih.gov/pubmed/32025948 http://dx.doi.org/10.1186/s40981-018-0192-z

Ejemplares similares

SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation
por: Deana, Cristian, et al.
Publicado: (2020)

Effects of Sugammadex and Neostigmine on Renal Biomarkers
por: Isik, Yasemin, et al.
Publicado: (2016)

Safety of sugammadex for myasthaenia gravis patients undergoing general anaesthesia: a retrospective database study
por: Nahara, Isao, et al.
Publicado: (2022)

Sugammadex affects emergence agitation in children undergoing strabismus surgery
por: Kim, Young Sung, et al.
Publicado: (2018)

Reversal by Sugammadex
por: Bajaj, Pramila
Publicado: (2009)

In the hour of Sugammadex
por: Chon, Jin Young
Publicado: (2013)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

Use of sugammadex in lung cancer patients undergoing video-assisted thoracoscopic lobectomy
por: Cho, Hyun Chul, et al.
Publicado: (2017)

Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?
por: Korkmaz, Muge O., et al.
Publicado: (2019)

Effect of sugammadex on the recovery profiles of cardiac patients undergoing non-cardiac surgery
por: Li, Bing, et al.
Publicado: (2021)

Safety and Efficacy of 4 mg·kg(−1) Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized Trial
por: Tang, Jiancheng, et al.
Publicado: (2023)

Benefits and risks of sugammadex
por: Park, Jong-Yeon
Publicado: (2015)

Sugammadex in pediatric patients
por: Choi, Jae Moon, et al.
Publicado: (2022)

Sugammadex in Emergency Situations
por: Motamed, Cyrus
Publicado: (2023)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Comment on: Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?
por: Kim, Yong H.
Publicado: (2019)

Sugammadex administration in pregnant patients undergoing non-obstetric surgery: a case series
por: Torres, Sara Martins, et al.
Publicado: (2021)

Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015)

Use of sugammadex in clinical practice
por: Park, Hee-Pyoung
Publicado: (2017)

Sugammadex: Anaphylaxis: case report
Publicado: (2021)

Sugammadex-induced anaphylactic shock
por: Kim, Ha-Jung, et al.
Publicado: (2020)

Cardiovascular adverse effects of sugammadex
por: Kapoor, Mukul Chandra
Publicado: (2020)

Effect of intraoperative neuromonitoring on efficacy and safety using sugammadex in thyroid surgery: randomized clinical trial
por: Gunes, Mehmet Emin, et al.
Publicado: (2019)

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
por: Kim, Young-Sung, et al.
Publicado: (2021)

Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery
por: Mostoller, Kate, et al.
Publicado: (2020)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations
por: Oh, Seok Kyeong, et al.
Publicado: (2023)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Sugammadex: clinical development and practical use
por: Fuchs-Buder, Thomas, et al.
Publicado: (2013)

Skin test after anaphylaxis to sugammadex
por: Hong, Sung Jin, et al.
Publicado: (2020)

Evaluation of the Toxicity of Sugammadex in Zebrafish Larvae
por: Kim, Woon Young, et al.
Publicado: (2020)

Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2020)

Sugammadex to prevent postoperative nausea and vomiting?
por: Kendall, Mark C., et al.
Publicado: (2018)

Adverse Effects of Sugammadex on the Cardiovascular System
por: Kadiyala, Mamatha, et al.
Publicado: (2023)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
por: Kim, Gunn Hee, et al.
Publicado: (2019)

Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study
por: Oh, Chung-Sik, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pje3kphivn5viueqcj5e5cgf67